Search PubMed⌕ Search

Biomedical subjects

M Roumiantzeff

Publications and source records attributed to M Roumiantzeff.

53 records · Page 3Linked to original sources
PubMedDate not supplied

Experience with preexposure rabies vaccination.

Preexposure rabies vaccination, presently limited to high-risk target populations, is facilitated by cell culture vaccines. Officially recommended programs comprise either two doses administered on days 0 and 28 or three doses given on days 0, 7, and 21 or 28. A first booster 1 year later ensures a good duration of immunity; follow-up studies now cover 5-8 years. These results were obtained by the intramuscular and subcutaneous injection routes; intradermal programs have been explored with the aim of reducing costs. Preexposure immunization is well tolerated, despite some systemic allergic reactions. Efficacy has been observed universally, but certain factors may affect results. Several lines of evidence favor an extension of preexposure vaccination. In Scandinavian countries, the majority of vaccine doses are used preexposure, while about 40%, 15%, and 10% are so used in the United Kingdom, the United States, and France, respectively. However, preventive immunization is rare in developing countries, where the risk of infection is maximal and permanent. The more economical new vaccines, such as purified Vero rabies vaccine, permit a reevaluation of preventive vaccination. Vaccine combinations including rabies may prove economical.

Humans↗
PubMedDate not supplied

Seroimmunity following vaccination in infants by an inactivated poliovirus vaccine prepared on Vero cells.

An inactivated poliovirus vaccine prepared from cultures of Vero cells has been tested on 61 infants from two to 11 months of age (mean age, 4.3 months) for tolerance and serologic potency. Three doses of vaccine were given one month apart at the same time that diphtheria-tetanus-pertussis vaccine was injected at another body site. Poliovirus-neutralizing antibody titers were measured before the first and third injections and one month after each. The titer was considered positive when the dilution was greater than or equal to 1:4. The tolerance has been good. Thirty-one infants were assessable for serologic efficacy; all had significant serologic responses after two injections of polio vaccine, regardless of the titer of maternally transmitted antibodies before the immunizations. The third injection did not significantly increase the antibody titer observed after the first two doses.

Animals↗
PubMedDate not supplied

[A study of the serological response of Sudanese children to three associated immunizations (measles, tetanus, meningococcal A meningitis) (author's transl)].

The authors first emphasize the efficiency and economic value of associated immunizations in developping countries. They report the first data collected in a campaign of immunization with a single injection of an extemporaneous mixture of antimeasles, antitetanus and antimeningococcal meningitis vaccines. This campaign took place in the Republic of Suddan from may 1976 to july 1977 and concerned 87 children. The specifications of each vaccine as well as the procedures of vaccination and serological control are given. The study of serological rates shows: -- a good response for measles with, in Africa, an optimal âge of 6 months and a new injection 6 months later; -- a low and late antibodies rise in tetanus with a good immunological memory giving way to an acute rise under a 2nd injection one year later; -- an immediate increase of the basic low rate of meningococcic antibodies existing in most Suddanese children before the injection. The authors consider the advantage of using also anti C meningococcal vaccine and to add an inactivated poliomyelitic vaccine. They give notice of the good stability in tropical environment of the vaccinal mixture they used.

Bacterial Vaccines↗
PubMedDate not supplied

Mouse tumour tests for quality control of C. parvum preparations.

Description of two mouse tumor tests selected to control the quality of C. parvum pilot productions: transplanted Ehrlich's ascitic tumor in inbred Swiss mice and transplanted YC8 ascitic tumor in isogenic Balb/c mice. The results obtained during three years of control are analyzed, particularly accuracy, long range adequacy and reproducibility of tumor challenges and C, parvum stimulations. The effects of some parameters of the tumor tests, e.g. dose-responses, treatment schedules, tumor-host relationships and standard preparations are discussed.

Animals↗
PubMedDate not supplied

C. parvum skin testing antigen: study on guinea pig model.

A skin-testing antigen produced from C. parvum has been developed for exploring cell-mediated immunity and specially C. parvum specific cell-mediated immunity by delayed cutaneous hypersensitivity (DCH) reaction. The DCH antigen and the techniques of intradermal injection and multiple puncture are described. DCH reactions are carried out in C. parvum specifically sensitized guinea pigs: sensitization procedure and adjuvant (IFA and CFA) effects are reported. Measures of DCH reactions for different antigen doses at various times (5-24-48 h) are reported; classical Mantoux and multiple puncture reactions are compared. The specificity of these DCH reactions are explored by comparing C. parvum antigen and tuberculin reactions in corynebacterium and mycobacterium sensitized guinea pigs.

Animals↗